[Differential features of SSRIs].
The goal of this study is to review the pharmacologic profiles of the selective serotonin reuptake inhibitors (SSRIs) presently available, with particular emphasis placed on therapeutically relevant distinctions.
Departamento de Psiquiatría y Psicología Médica, Facultad de Medicina, Universidad de Navarra.
S
S
Cervera
D000818:Animals; D015283:Citalopram / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D003863:Depression / Q000503:physiopathology; D004347:Drug Interactions; D062787:Drug Overdose; D005473:Fluoxetine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D016666:Fluvoxamine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D006207:Half-Life; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy; D009325:Nausea / Q000139:chemically induced; D017374:Paroxetine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D011985:Receptors, Serotonin / Q000187:drug effects / Q000502:physiology; D012701:Serotonin / Q000502:physiology; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D020280:Sertraline / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced; D012894:Sleep Stages / Q000187:drug effects
D015283:Citalopram; D005473:Fluoxetine; D016666:Fluvoxamine; D017374:Paroxetine; D011985:Receptors, Serotonin; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline
Aspectos diferenciales de los ISRS.